Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40009005
Localisation
India
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
10/10/2024
Statut
Classification
1.5°C
Année cible
FY2033
Syngene International Limited commits to reduce absolute scope 1 and 2 GHG emissions 54.6% by FY2033 from a FY2023 base year. Syngene International Limited commits that 81.6% of its suppliers by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution will have science-based targets by FY2028.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
INE398R01022
Source : Science Based Targets initiative | Données publiques